Contributing factors to advanced brain aging in depression and anxiety disorders.
Contributing factors to advanced brain aging in depression and anxiety disorders.
复制标题
DOI:
10.1038/s41398-021-01524-2
复制
发表时间:
2021-07-21
影响因子:
6.8
通讯作者:
Penninx BWJH
中科院分区:
文献类型:
--
作者:
Han LKM;Schnack HG;Brouwer RM;Veltman DJ;van der Wee NJA;van Tol MJ;Aghajani M;Penninx BWJH
Depression and anxiety are common and often comorbid mental health disorders that represent risk factors for aging-related conditions. Brain aging has shown to be more advanced in patients with major depressive disorder (MDD). Here, we extend prior work by investigating multivariate brain aging in patients with MDD, anxiety disorders, or both, and examine which factors contribute to older-appearing brains. Adults aged 18–57 years from the Netherlands Study of Depression and Anxiety underwent structural MRI. A pretrained brain-age prediction model based on >2000 samples from the ENIGMA consortium was applied to obtain brain-predicted age differences (brain PAD, predicted brain age minus chronological age) in 65 controls and 220 patients with current MDD and/or anxiety. Brain-PAD estimates were associated with clinical, somatic, lifestyle, and biological factors. After correcting for antidepressant use, brain PAD was significantly higher in MDD (+2.78 years, Cohen’s d = 0.25, 95% CI −0.10-0.60) and anxiety patients (+2.91 years, Cohen’s d = 0.27, 95% CI −0.08-0.61), compared with controls. There were no significant associations with lifestyle or biological stress systems. A multivariable model indicated unique contributions of higher severity of somatic depression symptoms (b = 4.21 years per unit increase on average sum score) and antidepressant use (−2.53 years) to brain PAD. Advanced brain aging in patients with MDD and anxiety was most strongly associated with somatic depressive symptomatology. We also present clinically relevant evidence for a potential neuroprotective antidepressant effect on the brain-PAD metric that requires follow-up in future research.
登录
查看更多内容
DOI:
10.1176/appi.ajp.2018.17060595
发表时间:
2018-08-01
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Han LKM;Aghajani M;Clark SL;Chan RF;Hattab MW;Shabalin AA;Zhao M;Kumar G;Xie LY;Jansen R;Milaneschi Y;Dean B;Aberg KA;van den Oord EJCG;Penninx BWJH
通讯作者:
Penninx BWJH
影响因子:
16.2
作者:
Esposito K;Chiodini P;Colao A;Lenzi A;Giugliano D
通讯作者:
Giugliano D
影响因子:
11
作者:
Felger JC;Haroon E;Patel TA;Goldsmith DR;Wommack EC;Woolwine BJ;Le NA;Feinberg R;Tansey MG;Miller AH
通讯作者:
Miller AH
影响因子:
4.2
作者:
Bas-Hoogendam, Janna Marie;van Steenbergen, Henk;van der Wee, Nic J. A.
通讯作者:
van der Wee, Nic J. A.
影响因子:
4.8
作者:
Franke K;Gaser C;Manor B;Novak V
通讯作者:
Novak V